Can Hydrogen Gas Help Restore Smell Loss in Alzheimer's Disease?

Hydrogen gas and olfactory dysfunction in Alzheimer's disease: the Hydrogen-Olfactory-Limbic hypothesis

Research hubs: Brain & Nervous System · Immune System

Authors
Ligao Bao, Dunfu Eer
Journal
Frontiers in Aging Neuroscience
Year
2026
DOI
10.3389/fnagi.2026.1937419
Study Type
clinical
Peer Reviewed
Yes
Country
Japan
Health Condition
Alzheimer's Disease
Body System
Nervous System

TL;DR

People with Alzheimer's often lose their sense of smell before they even start forgetting things. Scientists think that hydrogen gas might help protect the brain cells involved in smelling, which could give us an early warning sign for the disease and possibly a new way to treat it.

Key Finding

Loss of smell in Alzheimer's disease remains poorly understood, and researchers propose using molecular hydrogen as an experimental tool — not a proven treatment — to study whether oxidative stress and inflammation contribute to this early symptom.

Summary

This paper proposes a new scientific hypothesis — called the Hydrogen-Olfactory-Limbic hypothesis — about a possible connection between hydrogen gas, smell loss, and Alzheimer's disease (AD). Loss of smell is often one of the earliest signs of AD, but scientists don't fully understand why it happens. The authors suggest that molecular hydrogen, which has shown antioxidant (cell-protecting) and anti-inflammatory effects in lab studies, could be used as a research tool to investigate what causes smell dysfunction in AD. No experiments were conducted — this is a theoretical framework meant to guide future research.

Practical Takeaway

This is a hypothesis paper, not a clinical trial, so no conclusions about hydrogen water's effect on Alzheimer's disease or smell loss can be drawn from it. It suggests that hydrogen may be worth studying in this context, but no human or animal experiments have yet tested this idea. Anyone interested in hydrogen for brain health should be aware that this research is still at the earliest theoretical stage.

Abstract (excerpt)

Olfactory dysfunction is increasingly recognized as an early clinical feature of Alzheimer's disease (AD), often preceding measurable cognitive impairment and associated with subsequent cognitive decline. Despite this relatively consistent clinical association, the anatomical, cellular…

Read the full abstract via DOI